211
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ever Smoking is Not Associated with Performed Spirometry while Occupational Exposure and Respiratory Symptoms are

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 341-348 | Received 26 Oct 2022, Accepted 06 Mar 2023, Published online: 17 Mar 2023

References

  • Global Initiative for Chronic Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 report). GOLD-REPORT-2022-v1.1–22Nov2021_WMV.pdf (goldcopd.org); 2022.
  • Global Initiative for Asthma (GINA). Global strategy for asthma management and preventions, updated 2021. GINA Full Report 2021 Front Cover ONLY (ginasthma.org); 2021.
  • Graham B, Steenbruggen I, Miller M, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:E70–E88. doi:10.1164/rccm.201908-1590ST
  • Townsend C, Lockey M, Velez I, et al. Spirometry in the occupational setting. J Occup Environ Med. 2020;42:228–245. doi:10.1097/00043764-200003000-00003
  • Redlich C, Tarlo S, Hankinson J, et al. Official American Thoracic Society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med. 2014;189(8):983–993. doi:10.1164/rccm.201402-0337ST
  • Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults. A consensus statement from the national lung health education program. Chest. 2000;117:1146–1161. doi:10.1378/chest.117.4.1146
  • Wells CD, Joo MJ. COPD and asthma: diagnostic accuracy requires spirometry. J Fam Pract. 2019;68:76–81.
  • Weidinger P, Nilsson J, Lindblad U. Adherence to diagnostic guidelines and quality indicators in asthma and COPD in Swedish primary care. Pharmacoepidemiol Drug Saf. 2009;18:393–400. doi:10.1002/pds.1734
  • Caramori G, Bettoncelli G, Tosatt R, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005;63:6–12. doi:10.4081/monaldi.2005.651
  • Joo M, Au J, Fitzgibbon D, McKell H, Lee M. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. J Gen Int Med. 2011;26:1272–1277. doi:10.1007/s11606-011-1770-1
  • Monteaguado M, Rodriguez-Blanco T, Parcet J, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol. 2011;47:226–233. doi:10.1016/S1579-2129(11)70057-X
  • Sokol K, Sharma G, Lin Y, Goldblum R. Choosing Wisely: adherence by physicians to recommended use of spirometry in the diagnosis and management of adult asthma. Am J Med. 2015;128:502–508. doi:10.1016/j.amjmed.2014.12.006
  • Heffler E, Crimi C, Mancuso S, et al. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48–52. doi:10.1016/j.rmed.2018.07.015
  • Roychowdhury P, Badwal J, Alkhatib F, et al. Spirometry utilization among patients with asthma. J Asthma Allergy. 2020;13:193–203. doi:10.2147/JAA.S254431
  • Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104:550–556. doi:10.1016/j.rmed.2009.10.023
  • Delgado A, Saletti-Cuesta L, López-Fernández L, Gil-Garrido N, Luna Del Castillo J. Gender inequalities in COPD decision-making in primary care. Respir Med. 2016;114:91–96. doi:10.1016/j.rmed.2016.03.017
  • Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med. 2004;98(12):1207–1213. doi:10.1016/j.rmed.2004.05.004
  • Koefoed MM, de Pont Christensen R, Søndergaard J, Ejg Jarbøl D. Lack of spirometry use in Danish patients initiating medication targeting obstructive lung disease. Respir Med. 2012;106(12):1743–1748. doi:10.1016/j.rmed.2012.09.012
  • Akbarshahi H, Ahmadi Z, Currow D, et al. No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial. ERJ Open Res. 2020;6(4):00342–2020. doi:10.1183/23120541.00342-2020
  • Bergström G, Persson M, Adiels M, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916–929. doi:10.1161/CIRCULATIONAHA.121.055340
  • Toren K, Olin AC, Lindberg A, et al. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS). Int J COPD. 2026;11:927–933.
  • Buist S, McBurnie MA, Vollmer WM, et al; On behalf of the Bold Collaborative Research Group. International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet. 2007;370:741–750. doi:10.1016/S0140-6736(07)61377-4
  • Brisman J, Kim JL, Olin AC, Torén K, Bake B. Spirometric reference equations for Swedish adults. Clin Physiol Funct Imaging. 2017;37:640–645. doi:10.1111/cpf.12349
  • Torén K, Brisman J, Järvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. Chest. 1993;104:600–608. doi:10.1378/chest.104.2.600
  • Torén K, Murgia N, Olin AC, et al. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population study – the SCAPIS pilot study. Int J COPD. 2017;12:2269–2275. doi:10.2147/COPD.S136308
  • Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586. doi:10.1136/thx.54.7.581
  • National Board of Health and Welfare. Nationella riktlinjer för vård vid astma och KOL [National guidelines for care of asthma and COPD]. Stöd för styrning och ledning (Artikelnummer 2018-1-36). Swedish. Swedish https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-riktlinjer/2020-12-7135.pdf. Accessed March 7, 2023.
  • Friedemann Smith C, Whitaker KL, Winstanley K, Wardle J. Smokers are less likely than non-smokers to seek help for a lung cancer ‘alarm’ symptom. Thorax. 2016;71:659–661. doi:10.1136/thoraxjnl-2015-208063
  • Walabyecki J, Adamosn J, Buckley KHL, et al. Experience of, awareness of - seeking for potential cancer symptoms in smokers and non-smokers: a cross-sectional study. PLosOne. 2017;12:e0183647. doi:10.1371/journal.pone.0183647
  • Jain V, Allison D, Andrews S, Mejia J, Mills P, Peterson M. Misdiagnosis among frequent exacerbators of clinically diagnosed asthma and COPD in absence of confirmation of airflow obstruction. Lung. 2015;193:505–512. doi:10.1007/s00408-015-9734-6
  • Roberts NJ, Smith SF, Partridge MR. Why is spirometry underused in the diagnosis of the breathless patient: a qualitative study. BMC Pulm Med. 2011;11:37. doi:10.1186/1471-2466-11-37
  • Rothnie KJ, Chandan JS, Goss HG, Müllerová H, Quint JK. Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care. Int J COPD. 2017;12:1663–1668. doi:10.2147/COPD.S133891
  • Segnan N, Ponti A, Battista RN, et al. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control. 1991;2:239–246. doi:10.1007/BF00052140
  • Humerfelt S, Eide GE, Kvåle G, Aarø LE, Gulsvik A. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. Eur Respir J. 1998;11:284–290. doi:10.1183/09031936.98.11020284
  • Swedish Work Enviroment Authority. Medical check-ups in working life[Medicinska kontroller i arbetslivet]. Vol. 3. Stockholm, Sweden: AFS; 2019. Swedish.
  • Lytras T, Kogevinas M, Kromhout H, et al. Occupational exposures and 20-year incidence of COPD: the European community respiratory health survey. Thorax. 2018;73:1008–1015. doi:10.1136/thoraxjnl-2017-211158
  • The Swedish Work Environment Authority. The work environment 2019 (2020:2). Arbetsmiljön 2019, rapport 2020:2 (av.se); 2019. Swedish.
  • Axelson O, Fredriksson M, Ekberg K. Use of the prevalence ratio vs. the prevalence odds ratio as a measure of risk in cross sectional studies. Occup Environ Med. 1994;51:574. doi:10.1136/oem.51.8.574
  • Bergström G, Berglund G, Blomberg A, et al. The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med. 2015;278(6):645–659. doi:10.1111/joim.12384
  • Bjork J, Strömberg U, Rosengren A, et al. Predicting participation in the population-based Swedish cardiopulmonary bio-image study (SCAPIS) using register data. Scand J Public Health. 2017;45:45-.49, 45, 45–49.